Indoco Remedies vs Peers
- Market cap
- ₹2,132 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹166.54 – ₹312.26
Indoco Remedies ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Indoco Remedies. Its P/E of 22.5 compares with a peer median of 22.5.
Indoco Remedies vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Indoco Remedies | 231.30 | -6.19% | 2,132 | 22.5 | 2.85 | 14.5% | +18.5% |
| Indoco Remedies | 231.30 | -6.19% | 2,132 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Indoco Remedies peer comparison — frequently asked questions
Who are Indoco Remedies' competitors?
Indoco Remedies' listed peers in Drug Manufacturers - Specialty & Generic include Indoco Remedies, ranked here by market capitalisation.
How does Indoco Remedies' P/E compare with its peers?
Indoco Remedies trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Indoco Remedies' peers?
By market capitalisation, the largest company in the group is Indoco Remedies at ₹2,132 crore, against ₹2,132 crore for Indoco Remedies.
Same Data For Peers
Trade Indoco Remedies With ATS
Track INDOCO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.